SCHEMBL17023180

SCHEMBL17023180

CCN1CCN(c2ccc(NC(=O)Oc3ccc(-c4cncc5ccccc45)c4nccnc34)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.49
MAPT P10636 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
FGFR3 P22607 4/20 0.47
NR4A1 P22736 1/20 0.45
ESR2 Q92731 1/20 0.45
LMNA P02545 1/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MITF O75030 1/20 0.41
RAD52 P43351 1/20 0.41
KDM1A O60341 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023142 0.91 FGFR3 (0.52) NPC1MAPTRAB9ASMN1; SMN2FGFR3
SCHEMBL1126298 0.87 FGFR3 (0.60) NPC1MAPTRAB9ASMN1; SMN2FGFR3
SCHEMBL17023029 0.81 FGFR3 (0.50) NPC1MAPTRAB9ASMN1; SMN2FGFR3
SCHEMBL17023072 0.81 GAA (0.53) NPC1MAPTRAB9AESR2KMT2A
SCHEMBL17023034 0.81 FGFR3 (0.49) RAB9ASMN1; SMN2FGFR3GAANPSR1
SCHEMBL12678269 0.78 FGFR3 (0.63) NPC1MAPTRAB9ASMN1; SMN2FGFR3
SCHEMBL17023109 0.77 HRH3 (0.41) FGFR3
SCHEMBL17023089 0.77 FGFR3 (0.48) NPC1MAPTRAB9ASMN1; SMN2FGFR3
SCHEMBL17023062 0.77 FGFR3 (0.66) NPC1MAPTRAB9ASMN1; SMN2FGFR3
SCHEMBL17023126 0.76 FGFR3 (0.77) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed